GW-8510

Suppliers

Names

[ CAS No. ]:
222036-17-1

[ Name ]:
GW-8510

Chemical & Physical Properties

[ Molecular Formula ]:
C21H15N5O3S2

[ Molecular Weight ]:
449.51

[ Appearance of Characters ]:
solid

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

Articles

Cytoplasmic nucleophosmin has elevated T199 phosphorylation upon which G2/M phase progression is dependent.

Sci. Rep. 5 , 11777, (2015)

The cytoplasmic mutant of nucleophosmin (NPMc) is found approximately in one-third of acute myeloid leukemia (AML) cases and is highly associated with normal karyotype. Whereas previous studies have f...

Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapy.

Antimicrob. Agents Chemother. 52(10) , 3710-7, (2008)

Development of a safe, effective, and inexpensive therapy for African trypanosomiasis is an urgent priority. In this study, we evaluated the validity of Trypanosoma brucei glycogen synthase kinase 3 (...


More Articles


Related Compounds

  • GW 9578
  • GW-406381
  • GW 766994
  • GW 627368
  • GW284543 hydrochloride
  • GW-1100
  • [(2S)-1-(tert-butoxy)-1-oxobutan-2-yl]carbamic acid
  • 1-(1-Amino-4,4-dimethylcyclohexyl)cyclobutan-1-ol
  • (9H-fluoren-9-yl)methyl 3-hydroxy-3-[4-(trifluoromethyl)phenyl]azetidine-1-carboxylate
  • 2-Amino-3-(2-fluoro-6-methoxyphenyl)-3-methylbutanoic acid
  • 4-[(3-methoxyazetidin-3-yl)methyl]-3-(trifluoromethyl)-1H-pyrazole
  • 1,1,1-Trifluoro-3-(3-methyl-1-benzofuran-2-yl)propan-2-amine
  • 1-{1-[4-Methoxy-3-(trifluoromethyl)phenyl]cyclopropyl}ethan-1-one
  • 3-Bromo-5-fluoropyridine-2-sulfonamide
  • N-[(2-chloro-6-methylpyridin-3-yl)methyl]hydroxylamine
  • 3-(5-Oxo-1,2,3,7-tetrahydropyrrolo[3,4-f]indol-6-yl)piperidine-2,6-dione
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.